FDA — authorised 20 September 2019
- Application: NDA213051
- Marketing authorisation holder: NOVO
- Status: supplemented
🇺🇸 Rybelsus in United States
FDA authorised Rybelsus on 20 September 2019
Marketing authorisations
FDA
- Status: approved
Other Metabolic approved in United States
Frequently asked questions
Is Rybelsus approved in United States?
Yes. FDA authorised it on 20 September 2019; FDA has authorised it.
Who is the marketing authorisation holder for Rybelsus in United States?
NOVO holds the US marketing authorisation.